Tyra Biosciences clinical trials we track

Check company identity source

Phase 2 3 trials

Drugs in these trials

Names as written in the registry records.

Latest recorded trial changes

Filters
Clear filters

· 1 field changed

Main study measure wording changed

Text changed; whether the study measures changed has not been verified. Saved text may be shortened.

Before: Measure: To assess the efficacy of TYRA-300 in LG IR-NMIBC participants Description: Complete response (CR) rate Time frame: at 3 months. After: Measure: To assess the efficacy of TYRA-300 in LG IR-NMIBC participants Description: Complete response (CR) rate at 3 months Time frame: at 3 months.

Check registry source